Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults

Technology appraisal guidance
Reference number: TA170
Published: 22 April 2009

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive
27 February 2012
(211.9 Kb 1 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 24 February 2012